Please login to the form below

Not currently logged in
Email:
Password:

Sanofi Genzyme

This page shows the latest Sanofi Genzyme news and features for those working in and with pharma, biotech and healthcare.

VCCP Health lands record haul at the PM Society Awards

VCCP Health lands record haul at the PM Society Awards

Target Award for Corporate Communications - H4B Manchester for Sanofi Genzyme.

Latest news

  • Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ Third time lucky? Sanofi cuts an $11.6bn deal to buy Bioverativ

    Sanofi is offering $105 apiece for all of Bioverativ’s outstanding shares, which is a two-thirds premium on the US-based company’s closing price ahead of the weekend. ... For Sanofi it is the biggest acquisition since buying rare disease specialist

  • NICE backs Sanofi's Kevzara for routine NHS use NICE backs Sanofi's Kevzara for routine NHS use

    Peter Kuiper, Sanofi Genzyme ’s general manager for UK and Ireland, said: “This recommendation brings us one step closer to making Kevzara available to adult patients with severe RA and reinforces ... Sanofi’s on-going commitment to helping people

  • Sanofi Genzyme brings The World Vs MS to Denmark Sanofi Genzyme brings The World Vs MS to Denmark

    Sanofi Genzyme brings The World Vs MS to Denmark. Firm's Comm uniqué Award winning campaign launches in another local market. ... This year the global campaign, on which H4B supported Sanofi Genzyme, won the social media strategy award at the 2017 Comm

  • Solid start for Dupixent as Sanofi raises 2017 outlook Solid start for Dupixent as Sanofi raises 2017 outlook

    All told, Sanofi reported a 6% increase in sales in the second quarter to 8.66bn, with buoyant growth at Sanofi's rare disease unit Genzyme and vaccines subsidiary Sanofi Pasteur ... Long-acting follow-up Toujeo provided some relief for Sanofi's insulin

  • McCann Health cleans up at The Creative Floor Awards 2017 McCann Health cleans up at The Creative Floor Awards 2017

    Additionally, the Sanofi Genzyme Europe MS Team was revealed as the Bravest Client, alongside Meta Mucil’s Akhilesh Negi, Andrew Crowe and Nitin Darbari. ... FCB Health. AMV BBDO. The Bloc. Havas Lynx. Sanofi Genzyme Europe MS.

More from news
Approximately 14 fully matching, plus 76 partially matching documents found.

Latest Intelligence

  • Medius Deal Watch table for February 2015 Medius Deal Watch table for February 2015

    Voyager Therapeutics/ Sanofi (Genzyme). Gene therapy - Parkinson's disease, Friedreich's ataxia and Huntington's disease.

  • Pharma deals during January 2014 Pharma deals during January 2014

    The other deal announced by Alnylam was the expansion of its deal with Sanofi (Genzyme unit_ to develop RNAi therapeutics in rare diseases. ... In 2008 Genzyme gained rights to ataluren from PTC Therapeutics at a cost of $100m.

  • Interview: Laure Thibaud, Sanofi Interview: Laure Thibaud, Sanofi

    overnight.”. The Genzyme deal, for which Thibaud was involved in the pre-acquisition stage of the agreement, as well as the company's subsequent integration into Sanofi, was particularly exciting, she ... Chris Viehbacher has said too that he was very

  • Who tops the pharma list? Who tops the pharma list?

    The latter, an antiplatelet agent it co-marketed with Sanofi, enjoyed 2011 sales of $9.4bn - but, with Plavix accounting for more than a third of BMS revenues in 2010, the ... For example, Sanofi's 2011 acquisition of Genzyme gave it access to an

  • Personalised medicine is driving new techniques in market research Personalised medicine is driving new techniques in market research

    Parallels in orphan diseases &oncology. Orphan diseases have become an important part of pharma strategy, with significant acquisitions including the deal between Sanofi and Genzyme and key collaborations such as

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Sobi names Holly May VP of sales and marketing, US Sobi names Holly May VP of sales and marketing, US

    at Sanofi Genzyme. ... Prior to her 17-year career at Sanofi, May held various sales positions at DuPont Pharmaceuticals and Endo.

  • Sanofi appoints Bill Sibold to lead its Genzyme business Sanofi appoints Bill Sibold to lead its Genzyme business

    Sanofi has appointed Bill Sibold as executive vice president for Sanofi Genzyme in a move that will also see he join the company's executive committee. ... Previously head of Sanofi Genzyme’s multiple sclerosis, oncology and immunology organisation,

  • Dr Irina Antonijevic joins vasopharm Dr Irina Antonijevic joins vasopharm

    Most recently, Dr Antonijevic served as global head of early development in neurology, multiple sclerosis and ophthalmology at Sanofi Genzyme in the US.

  • ImmuneXcite boosts senior leadership ImmuneXcite boosts senior leadership

    Genzyme. DeWitt is senior director of investments at Sanofi-Genzyme BioVentures and brings business leadership experience from Springboard Enterprises, Permeon Biologics and Flagship Ventures. ... He is chairman of the board of Idera Pharmaceuticals and

  • Former Genzyme group vice president joins Vedanta Biosciences Former Genzyme group vice president joins Vedanta Biosciences

    Former Genzyme group vice president joins Vedanta Biosciences. Dr Bruce Roberts takes up the role of chief scientific officer. ... He first joined Sanofi Genzyme as general manager of its Cambridge, UK-based therapeutic antibody centre in 2004 before

More from appointments
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics